IC
KNSA icon

Ikarian Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Ikarian Capital’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-59,422
Closed -$677K – 225
2021
Q3 		$677K Buy
+59,422
New +$774K 0.16% 175
2021
Q2 		– Sell
-51,273
Closed -$949K – 275
2021
Q1 		$949K Sell
51,273
-50,000
-49% -$1.02M 0.14% 238
2020
Q4 		$1.79M Sell
101,273
-241,725
-70% -$4.25M 0.33% 160
2020
Q3 		$5.25M Buy
342,998
+314,724
+1,113% +$5.91M 1.46% 67
2020
Q2 		$720K Sell
28,274
-330,650
-92% -$6.91M 0.22% 127
2020
Q1 		$5.56M Buy
+358,924
New +$5.62M 2.07% 58

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return